- Report
- April 2026
- 59 Pages
Global
From €16991EUR$17,995USD£14,184GBP
- Report
- December 2025
- 41 Pages
Global
From €9438EUR$9,995USD£7,878GBP
- Report
- December 2025
- 72 Pages
Global
From €16991EUR$17,995USD£14,184GBP
- Clinical Trials
- November 2025
- 502 Pages
Global
From €3258EUR$3,450USD£2,719GBP
- Report
- November 2025
- 82 Pages
Global
From €16991EUR$17,995USD£14,184GBP
- Report
- November 2025
Global
From €7082EUR$7,500USD£5,912GBP
- Report
- November 2026
- 194 Pages
Global
From €5524EUR$5,850USD£4,611GBP
- Report
- September 2026
- 48 Pages
Global
From €4674EUR$4,950USD£3,902GBP
- Report
- August 2026
- 143 Pages
Global
From €4391EUR$4,650USD£3,665GBP
- Report
- July 2026
- 120 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- July 2026
- 222 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 135 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 140 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 135 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 137 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 135 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 137 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 135 Pages
Global
From €4580EUR$4,850USD£3,823GBP
- Report
- June 2026
- 116 Pages
Global
From €4391EUR$4,650USD£3,665GBP
- Report
- May 2026
- 136 Pages
Global
From €4580EUR$4,850USD£3,823GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more